Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-650032 (Asunaprevir) in Chronic Hepatitis C Genotype 1
NCT00722358Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of asunaprevir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Dec 2008; status: completed.
02
Drugs
asunaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00722358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00722358.